Shattuck Labs, Inc. (NASDAQ:STTK – Get Free Report) was the recipient of a large increase in short interest in June. As of June 15th, there was short interest totalling 2,171,700 shares, an increase of 21.3% from the May 31st total of 1,790,000 shares. Based on an average trading volume of 331,500 shares, the short-interest ratio is currently 6.6 days. Currently, 5.3% of the company’s shares are sold short.
Analysts Set New Price Targets
A number of equities research analysts have commented on STTK shares. Needham & Company LLC reduced their price objective on Shattuck Labs from $12.00 to $8.00 and set a “buy” rating for the company in a research note on Friday, June 14th. Citigroup reduced their price target on shares of Shattuck Labs from $10.00 to $9.00 and set a “buy” rating for the company in a research report on Monday, June 17th. BTIG Research downgraded shares of Shattuck Labs from a “buy” rating to a “neutral” rating in a report on Monday, June 17th. Finally, HC Wainwright dropped their price objective on shares of Shattuck Labs from $28.00 to $16.00 and set a “buy” rating on the stock in a research note on Thursday, June 20th.
View Our Latest Stock Report on Shattuck Labs
Insider Activity
Institutional Trading of Shattuck Labs
A number of large investors have recently added to or reduced their stakes in STTK. Franklin Resources Inc. bought a new position in shares of Shattuck Labs during the 4th quarter valued at approximately $11,663,000. Vanguard Group Inc. increased its position in Shattuck Labs by 38.2% in the first quarter. Vanguard Group Inc. now owns 1,819,926 shares of the company’s stock worth $16,270,000 after buying an additional 502,860 shares during the last quarter. Monashee Investment Management LLC bought a new stake in shares of Shattuck Labs in the fourth quarter valued at $713,000. Pinnacle Associates Ltd. lifted its position in shares of Shattuck Labs by 13.9% during the 1st quarter. Pinnacle Associates Ltd. now owns 521,246 shares of the company’s stock valued at $4,660,000 after buying an additional 63,800 shares during the last quarter. Finally, SG Americas Securities LLC bought a new position in shares of Shattuck Labs during the 4th quarter worth $268,000. Hedge funds and other institutional investors own 58.74% of the company’s stock.
Shattuck Labs Trading Up 8.3 %
Shares of Shattuck Labs stock opened at $4.18 on Monday. The stock has a fifty day simple moving average of $7.70 and a 200 day simple moving average of $8.43. The company has a market capitalization of $198.76 million, a P/E ratio of -2.00 and a beta of 1.74. Shattuck Labs has a 12-month low of $1.33 and a 12-month high of $11.76.
Shattuck Labs (NASDAQ:STTK – Get Free Report) last released its earnings results on Thursday, May 2nd. The company reported ($0.37) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.45) by $0.08. Shattuck Labs had a negative return on equity of 64.85% and a negative net margin of 3,133.63%. The company had revenue of $1.15 million during the quarter, compared to analyst estimates of $0.30 million. Shattuck Labs’s quarterly revenue was up 2200.0% on a year-over-year basis. On average, analysts predict that Shattuck Labs will post -1.56 EPS for the current year.
Shattuck Labs Company Profile
Shattuck Labs, Inc, a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers.
Further Reading
- Five stocks we like better than Shattuck Labs
- How to Invest in Biotech Stocks
- Chewy Stock Surges on Roaring Kitty’s Disclosure of Major Stake
- 10 Best Airline Stocks to Buy
- How to Invest in Gold: A Complete Guide
- What is the Dogs of the Dow Strategy? Overview and Examples
- 3 Stocks Wall Street Could Be Watching on Fannie Mae’s Rally
Receive News & Ratings for Shattuck Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shattuck Labs and related companies with MarketBeat.com's FREE daily email newsletter.